MannKind Corp. (MNKD)
4.00
+0.05
(+1.27%)
USD |
NASDAQ |
Aug 31, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
MannKind Cash from Operations (TTM) : -8.217M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.217M |
| March 31, 2026 | 19.19M |
| December 31, 2025 | 18.26M |
| September 30, 2025 | 48.21M |
| June 30, 2025 | 33.98M |
| March 31, 2025 | 28.93M |
| December 31, 2024 | 42.11M |
| September 30, 2024 | 41.21M |
| June 30, 2024 | 40.60M |
| March 31, 2024 | 39.42M |
| December 31, 2023 | 33.90M |
| September 30, 2023 | 9.885M |
| June 30, 2023 | -26.83M |
| March 31, 2023 | -61.36M |
| December 31, 2022 | -80.70M |
| September 30, 2022 | -90.65M |
| June 30, 2022 | -77.76M |
| March 31, 2022 | -67.23M |
| December 31, 2021 | -61.71M |
| September 30, 2021 | -49.13M |
| June 30, 2021 | -47.40M |
| March 31, 2021 | -29.64M |
| December 31, 2020 | -28.13M |
| September 30, 2020 | -33.47M |
| June 30, 2020 | -72.06M |
| Date | Value |
|---|---|
| March 31, 2020 | -88.10M |
| December 31, 2019 | -88.48M |
| September 30, 2019 | -58.39M |
| June 30, 2019 | -20.26M |
| March 31, 2019 | -27.68M |
| December 31, 2018 | -37.73M |
| September 30, 2018 | -92.70M |
| June 30, 2018 | -102.05M |
| March 31, 2018 | -94.94M |
| December 31, 2017 | -64.78M |
| September 30, 2017 | -47.55M |
| June 30, 2017 | -47.35M |
| March 31, 2017 | -38.82M |
| December 31, 2016 | -78.09M |
| September 30, 2016 | -88.72M |
| June 30, 2016 | -85.54M |
| March 31, 2016 | -91.84M |
| December 31, 2015 | -58.06M |
| September 30, 2015 | -70.42M |
| June 30, 2015 | 49.70M |
| March 31, 2015 | 44.10M |
| December 31, 2014 | 4.086M |
| September 30, 2014 | 5.779M |
| June 30, 2014 | -127.37M |
| March 31, 2014 | -133.70M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| United Therapeutics Corp. | 1.682B |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Gilead Sciences, Inc. | 13.55B |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Ocugen, Inc. | -60.87M |